42.Krusche T, Worret WI. Mechanical properties of keloids in vivo during treatment with intralesional triamcinolone acetonide. Arch Dermatol Res, 1995, 287(3-4): 289.
54.Ahlering PA. Topical silastic gel sheeting for treating and controlling hypertrophic and keloid scars: case study. Dermatol Nurs, 1995, 7(5): 295.
65.Ollstein RN, Siegel HW, Gillooley JF, et al. Treatment of keloids by combined surgical excision and immediate postoperative X-ray therapy. Ann Plast Surg, 1981, 7(4): 281.
7Naitoh M, Hosokawa N, Kubota H, et al. Upregulation of HSP47 and collagen type III in the dermal fibrotie disease, keloid[J]. Bioehem Biophys Res Commun, 2001,280(5): 1316- 1322.
8Tsou R, Cole J K, Nathens A B, et al. Analysis of hypertrophic and normal scar gene expression with cDNA microarrays [J]. J Burn Care Rehabil, 2000,21(6):541-550.
9Logan N, Graham A, Zhao X,et al. E2F-8: an E2F family member with a similar organization of DNA-binding domains to E2F-7[J].Oncogene, 2005,24(31) :5000-5004.
10Johnson D G, K Ohtani Nevins J R. Autoregulatory control of E2F1 expression in response to positive and negative regulators of cell cycle progression[J]. Genes Dev, 1994, 8 (13): 1514- 1525.
